RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Medical Imaging Projection System (MIPS)

Product
Developers: Panasonic Corporation
Date of the premiere of the system: July, 2019
Branches: Pharmaceutics, medicine, health care

2019: Announcement

At the end of June, 2019 the Panasonic company presented the solution for medical visualization of MIPS (Medical Imaging Projection System). It will allow surgeons "look" in bodies of the patient, showing arrangement of blood vessels, nerves and tumors during transaction.

The system developed together with the University of Kyoto and the producer of the medical equipment Mitaka Kohki uses the infrared camera and a projector to display directly on a body of the patient of the line of a resection and other information, at the same time monitoring the movement and possible shift of internals.

Panasonic provided a system which will allow surgeons "look" in bodies of the patient

These data are very important, for example, at liver operations when the slightest incorrect movement can cause abundant bleeding. Deleting a tumor, the surgeon should control its arrangement constantly. The preliminary information is given here by a computer tomography and other researches.

Besides, the ICG method at which the doctor enters into the patient's organism the dye shining in infrared light (Indo-cyanine green, ICG) is even more often used, and executes a resection, watching the centers of fluorescent ICG in real time using the infrared camera. At the same time it should switch constantly a look between the monitor and the operating table.

According to developers, MIPS simplifies process — the device receives the image from the infrared camera and projects it directly on the patient. Optical axises of the camera and a projector are aligned with a high accuracy therefore the doctor will be able to monitor any movements or changes of a form of body in real time. Besides, the device lights with this world space around the operated area, exempting from need for additional lamps. 

By the end of June, 2019 of MIPS it was approved by the Japanese agency of medical research and development (AMED) that allowed to start clinical trials of a system.[1]

Notes